Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Arrhythmias

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 277 articles:
HTML format



Single Articles


    January 2020
  1. BOWRIN K, Briere JB, Fauchier L, Coleman C, et al
    Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France.
    PLoS One. 2020;15:e0225301.
    PubMed     Abstract available


  2. MCALISTER FA, Mian R, Oldgren J, Wallentin L, et al
    Hypertension prevalence but not control varies across the spectrum of risk in patients with atrial fibrillation: A RE-LY atrial fibrillation registry sub-study.
    PLoS One. 2020;15:e0226259.
    PubMed     Abstract available


  3. CHANG NC, Hu P, Chen TH, Mao CT, et al
    Drug-eluting versus bare-metal stents for first myocardial infarction in patients with atrial fibrillation: A nationwide population-based cohort study.
    PLoS One. 2020;15:e0227571.
    PubMed     Abstract available


  4. SEMAKULA JR, Mouton JP, Jorgensen A, Hutchinson C, et al
    A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa.
    PLoS One. 2020;15:e0227458.
    PubMed     Abstract available


  5. KIM T, Kim KS, Suh GJ, Kwon WY, et al
    Duty cycle of 33% increases cardiac output during cardiopulmonary resuscitation.
    PLoS One. 2020;15:e0228111.
    PubMed     Abstract available


  6. HSIEH HL, Hsu SC, Cheng HS, Chen CY, et al
    The influence of atrial fibrillation on the mortality of incident ESRD patients undergoing maintenance hemodialysis.
    PLoS One. 2020;15:e0228405.
    PubMed     Abstract available


  7. WALEK P, Sielski J, Gorczyca I, Roskal-Walek J, et al
    Left atrial mechanical remodelling assessed as the velocity of left atrium appendage wall motion during atrial fibrillation is associated with maintenance of sinus rhythm after electrical cardioversion in patients with persistent atrial fibrillation.
    PLoS One. 2020;15:e0228239.
    PubMed     Abstract available


  8. MOON I, Lee SY, Kim HK, Han KD, et al
    Trends of the prevalence and incidence of hypertrophic cardiomyopathy in Korea: A nationwide population-based cohort study.
    PLoS One. 2020;15:e0227012.
    PubMed     Abstract available


  9. MOUSAVI S, Fotoohinasab A, Afghah F
    Single-modal and multi-modal false arrhythmia alarm reduction using attention-based convolutional and recurrent neural networks.
    PLoS One. 2020;15:e0226990.
    PubMed     Abstract available


  10. HSIEH YC, Hsieh WH, Li CH, Liao YC, et al
    Ventricular divergence correlates with epicardial wavebreaks and predicts ventricular arrhythmia in isolated rabbit hearts during therapeutic hypothermia.
    PLoS One. 2020;15:e0228818.
    PubMed     Abstract available


  11. FARRAHA M, Lu J, Trivic I, Barry MA, et al
    Development of a sheep model of atrioventricular block for the application of novel therapies.
    PLoS One. 2020;15:e0229092.
    PubMed     Abstract available


  12. GLINGE C, Engstrom T, Midgley SE, Tanck MWT, et al
    Seasonality of ventricular fibrillation at first myocardial infarction and association with viral exposure.
    PLoS One. 2020;15:e0226936.
    PubMed     Abstract available


  13. ZHAO H, Liu M, Chen Z, Mei K, et al
    Dose-response analysis between hemoglobin A1c and risk of atrial fibrillation in patients with and without known diabetes.
    PLoS One. 2020;15:e0227262.
    PubMed     Abstract available


  14. LOWN M, Brown M, Brown C, Yue AM, et al
    Machine learning detection of Atrial Fibrillation using wearable technology.
    PLoS One. 2020;15:e0227401.
    PubMed     Abstract available


    January 2019
  15. WALL C, Jankowski T, Naruka V, Mota P, et al
    Comparing the delay with different anticoagulants before elective electrical cardioversion for atrial fibrillation/flutter.
    PLoS One. 2019;14:e0210170.
    PubMed     Abstract available


  16. MATSUMOTO Y, Mori Y, Kageyama S, Arihara K, et al
    Changes in QTc interval in long-term hemodialysis patients.
    PLoS One. 2019;14:e0209297.
    PubMed     Abstract available


  17. CALDEIRA D, Alves D, Costa J, Ferreira JJ, et al
    Ibrutinib increases the risk of hypertension and atrial fibrillation: Systematic review and meta-analysis.
    PLoS One. 2019;14:e0211228.
    PubMed     Abstract available


  18. ANDRIE RP, Beiert T, Knappe V, Linhart M, et al
    Treatment with mononuclear cell populations improves post-infarction cardiac function but does not reduce arrhythmia susceptibility.
    PLoS One. 2019;14:e0208301.
    PubMed     Abstract available


  19. SHANG L, Zhao Y, Shao M, Sun H, et al
    The association of CHA2DS2-VASc score and carotid plaque in patients with non-valvular atrial fibrillation.
    PLoS One. 2019;14:e0210945.
    PubMed     Abstract available


  20. PARREIRA L, Marinheiro R, Carmo P, Amador P, et al
    Isolated diastolic potentials as predictors of success in ablation of right ventricular outflow tract idiopathic premature ventricular contractions.
    PLoS One. 2019;14:e0211232.
    PubMed     Abstract available


  21. PARK J, Choi EK, Han KD, Choi YJ, et al
    Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study.
    PLoS One. 2019;14:e0209593.
    PubMed     Abstract available


  22. VAFAIE M, Giannitsis E, Mueller-Hennessen M, Biener M, et al
    High-sensitivity cardiac troponin T as an independent predictor of stroke in patients admitted to an emergency department with atrial fibrillation.
    PLoS One. 2019;14:e0212278.
    PubMed     Abstract available


  23. GARCIA-SEMPERE A, Hurtado I, Bejarano-Quisoboni D, Rodriguez-Bernal C, et al
    Quality of INR control and switching to non-Vitamin K oral anticoagulants between women and men with atrial fibrillation treated with Vitamin K Antagonists in Spain. A population-based, real-world study.
    PLoS One. 2019;14:e0211681.
    PubMed     Abstract available


  24. HWANG JK, Gwag HB, Park KM, On YK, et al
    Outcomes of cardiac resynchronization therapy in patients with atrial fibrillation accompanied by slow ventricular response.
    PLoS One. 2019;14:e0210603.
    PubMed     Abstract available


  25. GHAZAL F, Theobald H, Rosenqvist M, Al-Khalili F, et al
    Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care.
    PLoS One. 2019;14:e0212974.
    PubMed     Abstract available


  26. MARTIN-YEBRA A, Martinez JP
    Automatic diagnosis of strict left bundle branch block using a wavelet-based approach.
    PLoS One. 2019;14:e0212971.
    PubMed     Abstract available


  27. YASAKA M, Minematsu K, Toyoda K, Mori E, et al
    Rivaroxaban administration after acute ischemic stroke: The RELAXED study.
    PLoS One. 2019;14:e0212354.
    PubMed     Abstract available


  28. PETRYSZYN P, Niewinski P, Staniak A, Piotrowski P, et al
    Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis.
    PLoS One. 2019;14:e0213198.
    PubMed     Abstract available


  29. CHAN YH, Lee KT, Kao YW, Huang CY, et al
    The comparison of non-vitamin K antagonist oral anticoagulants versus well-managed warfarin with a lower INR target of 1.5 to 2.5 in Asians patients with non-valvular atrial fibrillation.
    PLoS One. 2019;14:e0213517.
    PubMed     Abstract available


  30. KIM HM, Choi EK, Park CS, Cha MJ, et al
    Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in octogenarian patients with non-valvular atrial fibrillation.
    PLoS One. 2019;14:e0211766.
    PubMed     Abstract available


  31. AMIOKA M, Nakano Y, Ochi H, Onohara Y, et al
    Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.
    PLoS One. 2019;14:e0213208.
    PubMed     Abstract available


  32. BARMANO N, Charitakis E, Kronstrand R, Walfridsson U, et al
    The association between alcohol consumption, cardiac biomarkers, left atrial size and re-ablation in patients with atrial fibrillation referred for catheter ablation.
    PLoS One. 2019;14:e0215121.
    PubMed     Abstract available


  33. MURGIA F, Melotti R, Foco L, Gogele M, et al
    Effects of smoking status, history and intensity on heart rate variability in the general population: The CHRIS study.
    PLoS One. 2019;14:e0215053.
    PubMed     Abstract available


  34. SOLEVAG AL, Luong D, Lee TF, O'Reilly M, et al
    Non-perfusing cardiac rhythms in asphyxiated newborn piglets.
    PLoS One. 2019;14:e0214506.
    PubMed     Abstract available


  35. KIM YG, Shim J, Boo KY, Kim DY, et al
    Different influence of cardiac hemodynamics on thromboembolic events in patients with paroxysmal and non-paroxysmal atrial fibrillation.
    PLoS One. 2019;14:e0214743.
    PubMed     Abstract available


  36. MEINEL TR, Frey S, Arnold M, Kendroud S, et al
    Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants - A systematic review.
    PLoS One. 2019;14:e0213379.
    PubMed     Abstract available


  37. AMIN A, Garcia Reeves AB, Li X, Dhamane A, et al
    Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure.
    PLoS One. 2019;14:e0213614.
    PubMed     Abstract available


  38. CHANG YJ, Hsiao HJ, Hsia SH, Lin JJ, et al
    Analysis of clinical parameters and echocardiography as predictors of fatal pediatric myocarditis.
    PLoS One. 2019;14:e0214087.
    PubMed     Abstract available


  39. KORNEJ J, Zeynalova S, Thiery J, Burkhardt R, et al
    Association between echocardiographic parameters and biomarkers in probands with atrial fibrillation and different PR interval lengths: Insight from the epidemiologic LIFE Adult Study.
    PLoS One. 2019;14:e0212627.
    PubMed     Abstract available


  40. DONG G, Liang F, Sun B, Wang C, et al
    Presence and function of stress granules in atrial fibrillation.
    PLoS One. 2019;14:e0213769.
    PubMed     Abstract available


  41. BEGG GA, O'Neill J, Sohaib A, McLean A, et al
    Multicentre randomised trial comparing contact force with electrical coupling index in atrial flutter ablation (VERISMART trial).
    PLoS One. 2019;14:e0212903.
    PubMed     Abstract available


  42. HERNANDEZ-ROMERO I, Guillem MS, Figuera C, Atienza F, et al
    Optical imaging of voltage and calcium in isolated hearts: Linking spatiotemporal heterogeneities and ventricular fibrillation initiation.
    PLoS One. 2019;14:e0215951.
    PubMed     Abstract available


  43. HIGUCHI S, Kabeya Y, Matsushita K, Arai N, et al
    Incidence and complications of perioperative atrial fibrillation after non-cardiac surgery for malignancy.
    PLoS One. 2019;14:e0216239.
    PubMed     Abstract available


  44. KOEKTUERK B, Koektuerk O, Yorgun H, Guelker JE, et al
    Long-term impact of a bonus freeze on clinical outcome: Analysis of effective and non-effective bonus freezes in cryoballoon ablation.
    PLoS One. 2019;14:e0214231.
    PubMed     Abstract available


  45. BELHAMADIA Y, Grenier J
    Modeling and simulation of hypothermia effects on cardiac electrical dynamics.
    PLoS One. 2019;14:e0216058.
    PubMed     Abstract available


  46. HAN S, Jeong HS, Kim H, Suh HS, et al
    The treatment pattern and adherence to direct oral anticoagulants in patients with atrial fibrillation aged over 65.
    PLoS One. 2019;14:e0214666.
    PubMed     Abstract available


  47. GIANFRANCHESCO FILIPPI M, de Castro Ferreira Lima M, Paes AC, Sarita Cruz Aleixo A, et al
    Evaluation of heart rate variability and behavior of electrocardiographic parameters in dogs affected by chronic Monocytic Ehrlichiosis.
    PLoS One. 2019;14:e0216552.
    PubMed     Abstract available


  48. POLI D, Antonucci E, Ageno W, Bertu L, et al
    Oral anticoagulation in very elderly patients with atrial fibrillation: Results from the prospective multicenter START2-REGISTER study.
    PLoS One. 2019;14:e0216831.
    PubMed     Abstract available


  49. WASSER K, Weber-Kruger M, Jurries F, Liman J, et al
    The cardiac diagnostic work-up in stroke patients-A subanalysis of the Find-AFRANDOMISED trial.
    PLoS One. 2019;14:e0216530.
    PubMed     Abstract available


  50. CHAN C, Daly M, Melton I, Crozier I, et al
    Two major earthquakes in Christchurch were not associated with increased ventricular arrhythmias: Analysis of implanted defibrillator diagnostics.
    PLoS One. 2019;14:e0216521.
    PubMed     Abstract available


  51. PEYTZ NC, Jabbari R, Bojesen SE, Nordestgaard B, et al
    Physical activity and risk of instant and 28-day case-fatality in myocardial infarction.
    PLoS One. 2019;14:e0217398.
    PubMed     Abstract available


  52. HALAMEK J, Leinveber P, Viscor I, Smisek R, et al
    The relationship between ECG predictors of cardiac resynchronization therapy benefit.
    PLoS One. 2019;14:e0217097.
    PubMed     Abstract available


  53. PICON A, Irusta U, Alvarez-Gila A, Aramendi E, et al
    Mixed convolutional and long short-term memory network for the detection of lethal ventricular arrhythmia.
    PLoS One. 2019;14:e0216756.
    PubMed     Abstract available


  54. ARGENZIANO MA, Doss MX, Tabler M, Sachinidis A, et al
    Transcriptional changes associated with advancing stages of heart failure underlie atrial and ventricular arrhythmogenesis.
    PLoS One. 2019;14:e0216928.
    PubMed     Abstract available


  55. ROH E, Chung HS, Lee JS, Kim JA, et al
    Total cholesterol variability and risk of atrial fibrillation: A nationwide population-based cohort study.
    PLoS One. 2019;14:e0215687.
    PubMed     Abstract available


  56. SCHRODER J, Bouaziz O, Agner BR, Martinussen T, et al
    Recurrent event survival analysis predicts future risk of hospitalization in patients with paroxysmal and persistent atrial fibrillation.
    PLoS One. 2019;14:e0217983.
    PubMed     Abstract available


  57. SHETH H, McNally D, Santibanez-Koref M, Burn J, et al
    Association of stroke and bleed events in non-valvular atrial fibrillation patients with direct oral anticoagulant prescriptions in NHS England between 2013 and 2016.
    PLoS One. 2019;14:e0218878.
    PubMed     Abstract available


  58. MILES JA, Quispe R, Mehlman Y, Patel K, et al
    Racial differences and mortality risk in patients with heart failure and hyponatremia.
    PLoS One. 2019;14:e0218504.
    PubMed     Abstract available


  59. COZZOLINO F, Montedori A, Abraha I, Eusebi P, et al
    A diagnostic accuracy study validating cardiovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data-Value Project.
    PLoS One. 2019;14:e0218919.
    PubMed     Abstract available


  60. MESQUITA J, Maniar N, Baykaner T, Rogers AJ, et al
    Online webinar training to analyse complex atrial fibrillation maps: A randomized trial.
    PLoS One. 2019;14:e0217988.
    PubMed     Abstract available


  61. LUAN CW, Chang JJ, Hsu CM, Tsai MS, et al
    Risk of sudden sensorineural hearing loss in patients with dysrhythmia: A nationwide population-based cohort study.
    PLoS One. 2019;14:e0218964.
    PubMed     Abstract available


  62. MORA MT, Gomez JF, Morley G, Ferrero JM, et al
    Mechanistic investigation of Ca2+ alternans in human heart failure and its modulation by fibroblasts.
    PLoS One. 2019;14:e0217993.
    PubMed     Abstract available


  63. TOKUDA M, Yamashita S, Matsuo S, Kato M, et al
    Clinical significance of early recurrence of atrial fibrillation after cryoballoon vs. radiofrequency ablation-A propensity score matched analysis.
    PLoS One. 2019;14:e0219269.
    PubMed     Abstract available


  64. CERESNAK SR, Pass RH, Dubin AM, Yang L, et al
    Validation of a novel automated signal analysis tool for ablation of Wolff-Parkinson-White Syndrome.
    PLoS One. 2019;14:e0217282.
    PubMed     Abstract available


  65. PHILLIPS CT, Wang J, Celi LA, Zhang Z, et al
    Association of hypokalemia with an increased risk for medically treated arrhythmias.
    PLoS One. 2019;14:e0217432.
    PubMed     Abstract available


  66. GULPEN AJW, Ten Cate H, Henskens YMC, van Oerle R, et al
    The daily practice of direct oral anticoagulant use in patients with atrial fibrillation; an observational cohort study.
    PLoS One. 2019;14:e0217302.
    PubMed     Abstract available


  67. HUNG TW, Huang JY, Jong GP
    Long-term outcomes of dialysis in patients with chronic kidney disease and new-onset atrial fibrillation: A population-based cohort study.
    PLoS One. 2019;14:e0222656.
    PubMed     Abstract available


  68. DE JONG LA, Groeneveld J, Stevanovic J, Rila H, et al
    Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings.
    PLoS One. 2019;14:e0222658.
    PubMed     Abstract available


  69. ARON M, Herzog S, Parlitz U, Luther S, et al
    Spontaneous termination of chaotic spiral wave dynamics in human cardiac ion channel models.
    PLoS One. 2019;14:e0221401.
    PubMed     Abstract available


  70. KJERPESETH LJ, Selmer R, Ariansen I, Karlstad O, et al
    Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study.
    PLoS One. 2019;14:e0221500.
    PubMed     Abstract available


  71. FANJUL F, Campins A, Asensio J, Samperiz G, et al
    Interatrial blocks prevalence and risk factors for human immunodeficiency virus-infected persons.
    PLoS One. 2019;14:e0223777.
    PubMed     Abstract available


  72. BELLIN A, Berto P, Themistoclakis S, Chandak A, et al
    New oral anti-coagulants versus vitamin K antagonists in high thromboembolic risk patients.
    PLoS One. 2019;14:e0222762.
    PubMed     Abstract available


  73. SENONER T, Barbieri F, Semmler G, Adukauskaite A, et al
    Long-term performance of an atrial lead capable of accelerometer based detection of cardiac contractility in patients receiving cardiac resynchronisation therapy.
    PLoS One. 2019;14:e0222269.
    PubMed     Abstract available


  74. O'NEAL WT, Alam AB, Sandesara PB, Claxton JS, et al
    Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation.
    PLoS One. 2019;14:e0222147.
    PubMed     Abstract available


  75. ZENG H, Li Z, He J, Fu W, et al
    Dexmedetomidine for the prevention of postoperative delirium in elderly patients undergoing noncardiac surgery: A meta-analysis of randomized controlled trials.
    PLoS One. 2019;14:e0218088.
    PubMed     Abstract available


  76. WILSON LE, Luo X, Li X, Mardekian J, et al
    Clinical outcomes and treatment patterns among Medicare patients with nonvalvular atrial fibrillation (NVAF) and chronic kidney disease.
    PLoS One. 2019;14:e0225052.
    PubMed     Abstract available


  77. MICHOWITZ Y, Klempfner R, Shlomo N, Goldenberg I, et al
    Thrombocytopenia and thrombocytosis are associated with different outcome in atrial fibrillation patients on anticoagulant therapy.
    PLoS One. 2019;14:e0224709.
    PubMed     Abstract available


  78. HILL NR, Ayoubkhani D, McEwan P, Sugrue DM, et al
    Predicting atrial fibrillation in primary care using machine learning.
    PLoS One. 2019;14:e0224582.
    PubMed     Abstract available


  79. DOYEN M, Ge D, Beuchee A, Carrault G, et al
    Robust, real-time generic detector based on a multi-feature probabilistic method.
    PLoS One. 2019;14:e0223785.
    PubMed     Abstract available


  80. WANG G, Rao N, Liu D, Jiang H, et al
    Analysis of potential roles of combinatorial microRNA regulation in occurrence of valvular heart disease with atrial fibrillation based on computational evidences.
    PLoS One. 2019;14:e0221900.
    PubMed     Abstract available


  81. MOMO K, Kobayashi H, Sugiura Y, Yasu T, et al
    Prevalence of drug-drug interaction in atrial fibrillation patients based on a large claims data.
    PLoS One. 2019;14:e0225297.
    PubMed     Abstract available


  82. BEAN DM, Teo J, Wu H, Oliveira R, et al
    Semantic computational analysis of anticoagulation use in atrial fibrillation from real world data.
    PLoS One. 2019;14:e0225625.
    PubMed     Abstract available


  83. KONIG S, Boudriot E, Arya A, Lurz JA, et al
    Incidence and characteristics of ventricular tachycardia in patients after percutaneous coronary revascularization of chronic total occlusions.
    PLoS One. 2019;14:e0225580.
    PubMed     Abstract available


  84. BENCARDINO G, Spera FR, Pinnacchio G, Perna F, et al
    Prognostic significance of non-sustained ventricular tachycardia on stored electrograms in pacemaker recipients.
    PLoS One. 2019;14:e0225059.
    PubMed     Abstract available


  85. YOU CH, Lin CK, Chen PH, Park S, et al
    Clarithromycin use and the risk of mortality and cardiovascular events: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0226637.
    PubMed     Abstract available


  86. DIETL A, Winkel I, Pietrzyk G, Paulus M, et al
    Skeletal muscle alterations in tachycardia-induced heart failure are linked to deficient natriuretic peptide signalling and are attenuated by RAS-/NEP-inhibition.
    PLoS One. 2019;14:e0225937.
    PubMed     Abstract available


  87. SHAKIBFAR S, Krause O, Lund-Andersen C, Strycko F, et al
    Impact of device programming on the success of the first anti-tachycardia pacing therapy: An anonymized large-scale study.
    PLoS One. 2019;14:e0219533.
    PubMed     Abstract available


  88. WITASSEK F, Springer A, Adam L, Aeschbacher S, et al
    Health-related quality of life in patients with atrial fibrillation: The role of symptoms, comorbidities, and the type of atrial fibrillation.
    PLoS One. 2019;14:e0226730.
    PubMed     Abstract available


    January 2018
  89. BREMBILLA-PERROT B, Sellal JM, Olivier A, Villemin T, et al
    Influence of advancing age on clinical presentation, treatment efficacy and safety, and long-term outcome of inducible paroxysmal supraventricular tachycardia without pre-excitation syndromes: A cohort study of 1960 patients included over 25 years.
    PLoS One. 2018;13:e0187895.
    PubMed     Abstract available


  90. JIANG YQ, Tian Y, Zeng LJ, He SN, et al
    The safety and efficacy of hybrid ablation for the treatment of atrial fibrillation: A meta-analysis.
    PLoS One. 2018;13:e0190170.
    PubMed     Abstract available


  91. BEGG GA, Karim R, Oesterlein T, Graham LN, et al
    Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study.
    PLoS One. 2018;13:e0189936.
    PubMed     Abstract available


  92. SALIBA W, Rennert HS, Gronich N, Gruber SB, et al
    Association of atrial fibrillation and cancer: Analysis from two large population-based case-control studies.
    PLoS One. 2018;13:e0190324.
    PubMed     Abstract available


  93. KUCUKSEYMEN S, Cekin AH, Bayar N, Arslan S, et al
    A novel biomarker for prediction of atrial fibrillation susceptibility in patients with celiac disease.
    PLoS One. 2018;13:e0190382.
    PubMed     Abstract available


  94. FAYSSOIL A, Ben Yaou R, Ogna A, Chaffaut C, et al
    Left bundle branch block in Duchenne muscular dystrophy: Prevalence, genetic relationship and prognosis.
    PLoS One. 2018;13:e0190518.
    PubMed     Abstract available


  95. MARTIN B, Gabris-Weber BA, Reddy R, Romero G, et al
    Relaxin reverses inflammatory and immune signals in aged hearts.
    PLoS One. 2018;13:e0190935.
    PubMed     Abstract available


  96. LI X, Keshishian A, Hamilton M, Horblyuk R, et al
    Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach.
    PLoS One. 2018;13:e0191722.
    PubMed     Abstract available


  97. XU Y, Shoamanesh A, Schulman S, Dowlatshahi D, et al
    Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts.
    PLoS One. 2018;13:e0191137.
    PubMed     Abstract available


  98. CHOU CC, Lee HL, Chang PC, Wo HT, et al
    Left atrial emptying fraction predicts recurrence of atrial fibrillation after radiofrequency catheter ablation.
    PLoS One. 2018;13:e0191196.
    PubMed     Abstract available


  99. WANG X, Wang C, Ye M, Lin J, et al
    Left atrial concomitant surgical ablation for treatment of atrial fibrillation in cardiac surgery: A meta-analysis of randomized controlled trials.
    PLoS One. 2018;13:e0191354.
    PubMed     Abstract available


  100. KIM YG, Choi JI, Kim MN, Cho DH, et al
    Non-vitamin K antagonist oral anticoagulants versus warfarin for the prevention of spontaneous echo-contrast and thrombus in patients with atrial fibrillation or flutter undergoing cardioversion: A trans-esophageal echocardiography study.
    PLoS One. 2018;13:e0191648.
    PubMed     Abstract available


  101. OSADCHII OE
    Arrhythmogenic drugs can amplify spatial heterogeneities in the electrical restitution in perfused guinea-pig heart: An evidence from assessments of monophasic action potential durations and JT intervals.
    PLoS One. 2018;13:e0191514.
    PubMed     Abstract available


  102. EGGIMANN L, Blum S, Aeschbacher S, Reusser A, et al
    Risk factors for heart failure hospitalizations among patients with atrial fibrillation.
    PLoS One. 2018;13:e0191736.
    PubMed     Abstract available


  103. DONOVAN TM, Katz JE
    AMModels: An R package for storing models, data, and metadata to facilitate adaptive management.
    PLoS One. 2018;13:e0188966.
    PubMed     Abstract available


  104. BASSAND JP, Accetta G, Al Mahmeed W, Corbalan R, et al
    Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation.
    PLoS One. 2018;13:e0191592.
    PubMed     Abstract available


  105. CHARLTON B, Adeboyeje G, Barron JJ, Grady D, et al
    Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban.
    PLoS One. 2018;13:e0193912.
    PubMed     Abstract available


  106. VAN MIERT JHA, Bos S, Veeger NJGM, Meijer K, et al
    Clinical usefulness of the SAMe-TT2R2 score: A systematic review and simulation meta-analysis.
    PLoS One. 2018;13:e0194208.
    PubMed     Abstract available


  107. LING X, Zhou H, Ni Y, Wu C, et al
    Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? A meta-analysis of randomized controlled trials.
    PLoS One. 2018;13:e0193303.
    PubMed     Abstract available


  108. SKOWASCH D, Ringquist S, Nickenig G, Andrie R, et al
    Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
    PLoS One. 2018;13:e0194496.
    PubMed     Abstract available


  109. HANSEN PW, Sehested TSG, Fosbol EL, Torp-Pedersen C, et al
    Trends in warfarin use and its associations with thromboembolic and bleeding rates in a population with atrial fibrillation between 1996 and 2011.
    PLoS One. 2018;13:e0194295.
    PubMed     Abstract available


  110. NAKAMIZO T, Yamamoto M, Johkura K
    Changes in stroke risk by freedom-from-stroke time in simulated populations with atrial fibrillation: Freedom-from-event effect when event itself is a risk factor.
    PLoS One. 2018;13:e0194307.
    PubMed     Abstract available


  111. KULKARNI K, Xie X, Fernandez de Velasco EM, Anderson A, et al
    The influences of the M2R-GIRK4-RGS6 dependent parasympathetic pathway on electrophysiological properties of the mouse heart.
    PLoS One. 2018;13:e0193798.
    PubMed     Abstract available


  112. MCHORNEY CA, Crivera C, Laliberte F, Germain G, et al
    Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users.
    PLoS One. 2018;13:e0194099.
    PubMed     Abstract available


  113. BIAN S, Chen H, Wang L, Fei Y, et al
    Cardiac involvement in patients with primary biliary cholangitis: A 14-year longitudinal survey-based study.
    PLoS One. 2018;13:e0194397.
    PubMed     Abstract available


  114. SETHI NJ, Nielsen EE, Safi S, Feinberg J, et al
    Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    PLoS One. 2018;13:e0193924.
    PubMed     Abstract available


  115. SEONG CS, Gwag HB, Hwang JK, Park SJ, et al
    Clinical significance of fragmented QRS complexes or J waves in patients with idiopathic ventricular arrhythmias.
    PLoS One. 2018;13:e0194363.
    PubMed     Abstract available


  116. GRAY B, Gnanappa GK, Bagnall RD, Femia G, et al
    Relations between right ventricular morphology and clinical, electrical and genetic parameters in Brugada Syndrome.
    PLoS One. 2018;13:e0195594.
    PubMed     Abstract available


  117. CHALAZAN B, Mol D, Sridhar A, Alzahrani Z, et al
    Genetic modulation of atrial fibrillation risk in a Hispanic/Latino cohort.
    PLoS One. 2018;13:e0194480.
    PubMed     Abstract available


  118. LIP GYH, Pan X, Kamble S, Kawabata H, et al
    Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban.
    PLoS One. 2018;13:e0195950.
    PubMed     Abstract available


  119. MARCONDES L, Crawford J, Earle N, Smith W, et al
    Long QT molecular autopsy in sudden unexplained death in the young (1-40 years old): Lessons learnt from an eight year experience in New Zealand.
    PLoS One. 2018;13:e0196078.
    PubMed     Abstract available


  120. TURAKHIA MP, Shafrin J, Bognar K, Trocio J, et al
    Estimated prevalence of undiagnosed atrial fibrillation in the United States.
    PLoS One. 2018;13:e0195088.
    PubMed     Abstract available


  121. DALGAARD F, Ruwald MH, Lindhardt TB, Gislason GH, et al
    Patients with atrial fibrillation and permanent pacemaker: Temporal changes in patient characteristics and pharmacotherapy.
    PLoS One. 2018;13:e0195175.
    PubMed     Abstract available


  122. SANDERS JM, Steverson AB, Pawlowski AE, Schneider D, et al
    Atrial arrhythmia prevalence and characteristics for human immunodeficiency virus-infected persons and matched uninfected controls.
    PLoS One. 2018;13:e0194754.
    PubMed     Abstract available


  123. KRAUS M, Physick-Sheard P, Brito LF, Sargolzaei M, et al
    Marginal ancestral contributions to atrial fibrillation in the Standardbred racehorse: Comparison of cases and controls.
    PLoS One. 2018;13:e0197137.
    PubMed     Abstract available


  124. DANILOWICZ-SZYMANOWICZ L, Kaufmann D, Rozwadowska K, Kempa M, et al
    Microvolt T-wave alternans and autonomic nervous system parameters can be helpful in the identification of low-arrhythmic risk patients with ischemic left ventricular systolic dysfunction.
    PLoS One. 2018;13:e0196812.
    PubMed     Abstract available


  125. DONATE PUERTAS R, Jalabert A, Meugnier E, Euthine V, et al
    Analysis of the microRNA signature in left atrium from patients with valvular heart disease reveals their implications in atrial fibrillation.
    PLoS One. 2018;13:e0196666.
    PubMed     Abstract available


  126. JUNG Y, Cho Y, Kim N, Oh IY, et al
    Lipidomic profiling reveals free fatty acid alterations in plasma from patients with atrial fibrillation.
    PLoS One. 2018;13:e0196709.
    PubMed     Abstract available


  127. MENDOZA-SANCHEZ J, Silva F, Rangel L, Jaramillo L, et al
    Benefit, risk and cost of new oral anticoagulants and warfarin in atrial fibrillation; A multicriteria decision analysis.
    PLoS One. 2018;13:e0196361.
    PubMed     Abstract available


  128. YANG T, Yu L, Jin Q, Wu L, et al
    Activation recovery interval imaging of premature ventricular contraction.
    PLoS One. 2018;13:e0196916.
    PubMed     Abstract available


  129. CALVO M, Romero D, Le Rolle V, Behar N, et al
    Multivariate classification of Brugada syndrome patients based on autonomic response to exercise testing.
    PLoS One. 2018;13:e0197367.
    PubMed     Abstract available


  130. SIM MA, Liu W, Chew STH, Ti LK, et al
    Wider perioperative glycemic fluctuations increase risk of postoperative atrial fibrillation and ICU length of stay.
    PLoS One. 2018;13:e0198533.
    PubMed     Abstract available


  131. LEE HJ, Uhm JS, Hong YJ, Hur J, et al
    Altered myocardial characteristics of the preexcited segment in Wolff-Parkinson-White syndrome: A pilot study with cardiac magnetic resonance imaging.
    PLoS One. 2018;13:e0198218.
    PubMed     Abstract available


  132. MAKAM RCP, Hoaglin DC, McManus DD, Wang V, et al
    Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis.
    PLoS One. 2018;13:e0197583.
    PubMed     Abstract available


  133. LIU J, Bayer JD, Aschar-Sobbi R, Wauchop M, et al
    Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.
    PLoS One. 2018;13:e0197273.
    PubMed     Abstract available


  134. GWAG HB, Chun KJ, Hwang JK, Park SJ, et al
    Which antiarrhythmic drug to choose after electrical cardioversion: A study on non-valvular atrial fibrillation patients.
    PLoS One. 2018;13:e0197352.
    PubMed     Abstract available


  135. HUNG CS, Chang CH, Lin JW, Ho YL, et al
    The association between new onset atrial fibrillation and incident cancer-A nationwide cohort study.
    PLoS One. 2018;13:e0199901.
    PubMed     Abstract available


  136. GHAZAL F, Theobald H, Rosenqvist M, Al-Khalili F, et al
    Feasibility and outcomes of atrial fibrillation screening using intermittent electrocardiography in a primary healthcare setting: A cross-sectional study.
    PLoS One. 2018;13:e0198069.
    PubMed     Abstract available


  137. PAPPAS MA, Vijan S, Rothberg MB, Singer DE, et al
    Reducing age bias in decision analyses of anticoagulation for patients with nonvalvular atrial fibrillation - A microsimulation study.
    PLoS One. 2018;13:e0199593.
    PubMed     Abstract available


  138. DOBKOWSKA-CHUDON W, Wrobel M, Karlowicz P, Dabrowski A, et al
    Detecting cerebrovascular changes in the brain caused by hypertension in atrial fibrillation group using acoustocerebrography.
    PLoS One. 2018;13:e0199999.
    PubMed     Abstract available


  139. KAO WF, Hou SK, Huang CY, Chao CC, et al
    Assessment of the clinical efficacy of the heart spectrum blood pressure monitor for diagnosis of atrial fibrillation: An unblinded clinical trial.
    PLoS One. 2018;13:e0198852.
    PubMed     Abstract available


  140. FERNANDES FM, Silva EP, Martins RR, Oliveira AG, et al
    QTc interval prolongation in critically ill patients: Prevalence, risk factors and associated medications.
    PLoS One. 2018;13:e0199028.
    PubMed     Abstract available


  141. YANG PS, Pak HN, Park DH, Yoo J, et al
    Non-cardioembolic risk factors in atrial fibrillation-associated ischemic stroke.
    PLoS One. 2018;13:e0201062.
    PubMed     Abstract available


  142. KIM DH, Lee DI, Ahn J, Lee KN, et al
    Ischemic stroke risk during long-term follow up in patients with successful catheter ablation for atrial fibrillation in Korea.
    PLoS One. 2018;13:e0201061.
    PubMed     Abstract available


  143. SHIMAMOTO K, Miura F, Shimatani Y, Nishioka K, et al
    Pulmonary vein volume predicts the outcome of radiofrequency catheter ablation of paroxysmal atrial fibrillation.
    PLoS One. 2018;13:e0201199.
    PubMed     Abstract available


  144. COLL M, Ferrer-Costa C, Pich S, Allegue C, et al
    Role of genetic and electrolyte abnormalities in prolonged QTc interval and sudden cardiac death in end-stage renal disease patients.
    PLoS One. 2018;13:e0200756.
    PubMed     Abstract available


  145. SHAHID F, Rahmat NA, Lip GYH, Shantsila E, et al
    Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project.
    PLoS One. 2018;13:e0200373.
    PubMed     Abstract available


  146. MAYHUGH RE, Laurienti PJ, Fanning J, Gauvin L, et al
    Cardiac vagal dysfunction moderates patterns of craving across the day in moderate to heavy consumers of alcohol.
    PLoS One. 2018;13:e0200424.
    PubMed     Abstract available


  147. CLEMENTY N, Garcia B, Andre C, Bisson A, et al
    Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure.
    PLoS One. 2018;13:e0201517.
    PubMed     Abstract available


  148. LIOU YS, Yang FY, Chen HY, Jong GP, et al
    Antihyperglycemic drugs use and new-onset atrial fibrillation: A population-based nested case control study.
    PLoS One. 2018;13:e0197245.
    PubMed     Abstract available


  149. GULATI S, Solheim O, Carlsen SM, Oie LR, et al
    Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study.
    PLoS One. 2018;13:e0202575.
    PubMed     Abstract available


  150. CLASEN L, Eickholt C, Angendohr S, Jungen C, et al
    A modified approach for programmed electrical stimulation in mice: Inducibility of ventricular arrhythmias.
    PLoS One. 2018;13:e0201910.
    PubMed     Abstract available


  151. MA R, Qin Z, Yu X, Liu S, et al
    Selective ablation of the ligament of Marshall reduces ischemia and reperfusion-induced ventricular arrhythmias.
    PLoS One. 2018;13:e0203083.
    PubMed     Abstract available


  152. SANDGREN E, Rorsman C, Edvardsson N, Engdahl J, et al
    Stroke incidence and anticoagulation treatment in patients with pacemaker-detected silent atrial fibrillation.
    PLoS One. 2018;13:e0203661.
    PubMed     Abstract available


  153. CLAXTON JS, MacLehose RF, Lutsey PL, Norby FL, et al
    A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants.
    PLoS One. 2018;13:e0203599.
    PubMed     Abstract available


  154. TOMOMORI S, Nakano Y, Ochi H, Onohara Y, et al
    Maintenance of low inflammation level by the ZFHX3 SNP rs2106261 minor allele contributes to reduced atrial fibrillation recurrence after pulmonary vein isolation.
    PLoS One. 2018;13:e0203281.
    PubMed     Abstract available


  155. HUNTER MD, Park Moon Y, DeCarli C, Gutierrez J, et al
    Electrocardiographic left atrial abnormality and silent vascular brain injury: The Northern Manhattan Study.
    PLoS One. 2018;13:e0203774.
    PubMed     Abstract available


  156. MIYAZAKI M, Nakashima A, Nakamura Y, Sakamoto Y, et al
    Association between medication adherence and illness perceptions in atrial fibrillation patients treated with direct oral anticoagulants: An observational cross-sectional pilot study.
    PLoS One. 2018;13:e0204814.
    PubMed     Abstract available


  157. RIBEIRO WN, Yamada AT, Grupi CJ, da Silva GT, et al
    Premature atrial and ventricular complexes in outpatients referred from a primary care facility.
    PLoS One. 2018;13:e0204246.
    PubMed     Abstract available


  158. LIU LB, Guo YD, Xu AD, Zhong JX, et al
    Diagnostic value of STAF score in combination with D-dimer in cardioembolism.
    PLoS One. 2018;13:e0204838.
    PubMed     Abstract available


  159. GROPLER MRF, Dalal AS, Van Hare GF, Silva JNA, et al
    Can smartphone wireless ECGs be used to accurately assess ECG intervals in pediatrics? A comparison of mobile health monitoring to standard 12-lead ECG.
    PLoS One. 2018;13:e0204403.
    PubMed     Abstract available


  160. KIM D, Shim CY, Hong GR, Cho IJ, et al
    Sinus node dysfunction after surgical atrial fibrillation ablation with concomitant mitral valve surgery: Determinants and clinical outcomes.
    PLoS One. 2018;13:e0203828.
    PubMed     Abstract available


  161. KUBOTA K, Ooba N, Kamijima Y, Sato K, et al
    The use of anticoagulants in patients with non-valvular atrial fibrillation between 2005 and 2014: A drug utilization study using claims data in Japan.
    PLoS One. 2018;13:e0203380.
    PubMed     Abstract available


  162. DE VREESE LP, Mantesso U, De Bastiani E, Marangoni A, et al
    Anticholinergic burden in adult and elderly people with intellectual disabilities: Results from an Italian multicenter cross-sectional study.
    PLoS One. 2018;13:e0205897.
    PubMed     Abstract available


  163. MARZEC L, Raghavan S, Banaei-Kashani F, Creasy S, et al
    Device-measured physical activity data for classification of patients with ventricular arrhythmia events: A pilot investigation.
    PLoS One. 2018;13:e0206153.
    PubMed     Abstract available


  164. LEE SH, Park M, Park KM, Gwag HB, et al
    Corrected QT interval on the electrocardiogram after liver transplantation: Surrogate marker of poor clinical outcomes?
    PLoS One. 2018;13:e0206463.
    PubMed     Abstract available


  165. HWANG JK, Jeong DS, Gwag HB, Park KM, et al
    Staged hybrid procedure versus radiofrequency catheter ablation in the treatment of atrial fibrillation.
    PLoS One. 2018;13:e0205431.
    PubMed     Abstract available


  166. KATTELUS H, Kesaniemi YA, Huikuri H, Ukkola O, et al
    Cancer increases the risk of atrial fibrillation during long-term follow-up (OPERA study).
    PLoS One. 2018;13:e0205454.
    PubMed     Abstract available


  167. MORELLATO J, Chik W, Barry MA, Lu J, et al
    Quantitative spectral assessment of intracardiac electrogram characteristics associated with post infarct fibrosis and ventricular tachycardia.
    PLoS One. 2018;13:e0204997.
    PubMed     Abstract available


  168. TEPPER PG, Mardekian J, Masseria C, Phatak H, et al
    Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban.
    PLoS One. 2018;13:e0205989.
    PubMed     Abstract available


  169. JANG J, Tschabrunn CM, Barkagan M, Anter E, et al
    Three-dimensional holographic visualization of high-resolution myocardial scar on HoloLens.
    PLoS One. 2018;13:e0205188.
    PubMed     Abstract available


  170. KORNEJ J, Buttner P, Hammer E, Engelmann B, et al
    Circulating proteomic patterns in AF related left atrial remodeling indicate involvement of coagulation and complement cascade.
    PLoS One. 2018;13:e0198461.
    PubMed     Abstract available


  171. HE J, Sun L, Rong J, Wang H, et al
    A pyramid-like model for heartbeat classification from ECG recordings.
    PLoS One. 2018;13:e0206593.
    PubMed     Abstract available


  172. ROSTON TM, Haji-Ghassemi O, LaPage MJ, Batra AS, et al
    Catecholaminergic polymorphic ventricular tachycardia patients with multiple genetic variants in the PACES CPVT Registry.
    PLoS One. 2018;13:e0205925.
    PubMed     Abstract available


  173. SCHUMACHER K, Buttner P, Dagres N, Sommer P, et al
    Association between PR interval prolongation and electro-anatomical substrate in patients with atrial fibrillation.
    PLoS One. 2018;13:e0206933.
    PubMed     Abstract available


  174. SHAO M, Shang L, Shi J, Zhao Y, et al
    The safety and efficacy of second-generation cryoballoon ablation plus catheter ablation for persistent atrial fibrillation: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0206362.
    PubMed     Abstract available


  175. LIU L, Huang J, Zhang X, Tang X, et al
    Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis.
    PLoS One. 2018;13:e0199232.
    PubMed     Abstract available


  176. BAE HJ, Heo JH, Jung KH, Lee YS, et al
    Antithrombotic treatments in patients with acute ischemic stroke and non-valvular atrial fibrillation before introduction of non-vitamin K antagonist oral anticoagulants into practice in Korea.
    PLoS One. 2018;13:e0202803.
    PubMed     Abstract available


  177. AU-YEUNG WM, Reinhall PG, Bardy GH, Brunton SL, et al
    Development and validation of warning system of ventricular tachyarrhythmia in patients with heart failure with heart rate variability data.
    PLoS One. 2018;13:e0207215.
    PubMed     Abstract available


  178. JUNG YH, Kim YD, Kim J, Han SW, et al
    Atrial fibrillation in patients with first-ever stroke: Incidence trends and antithrombotic therapy before the event.
    PLoS One. 2018;13:e0209198.
    PubMed     Abstract available


    January 2017
  179. JAIN V, Marshall IJ, Crichton SL, McKevitt C, et al
    Trends in the prevalence and management of pre-stroke atrial fibrillation, the South London Stroke Register, 1995-2014.
    PLoS One. 2017;12:e0175980.
    PubMed     Abstract available


  180. ALDHOON B, Wichterle D, Peichl P, Cihak R, et al
    Outcomes of ventricular tachycardia ablation in patients with structural heart disease: The impact of electrical storm.
    PLoS One. 2017;12:e0171830.
    PubMed     Abstract available


  181. TAN D, Xu J, Shao S, Fu Y, et al
    Comparison of different inspiratory triggering settings in automated ventilators during cardiopulmonary resuscitation in a porcine model.
    PLoS One. 2017;12:e0171869.
    PubMed     Abstract available


  182. MACIANSKIENE R, Almanaityte M, Jekabsone A, Mubagwa K, et al
    Modulation of Human Cardiac TRPM7 Current by Extracellular Acidic pH Depends upon Extracellular Concentrations of Divalent Cations.
    PLoS One. 2017;12:e0170923.
    PubMed     Abstract available


  183. KORNEJ J, Hindricks G, Arya A, Sommer P, et al
    The APPLE Score - A Novel Score for the Prediction of Rhythm Outcomes after Repeat Catheter Ablation of Atrial Fibrillation.
    PLoS One. 2017;12:e0169933.
    PubMed     Abstract available


  184. ANSELMINO M, Scarsoglio S, Saglietto A, Gaita F, et al
    A Computational Study on the Relation between Resting Heart Rate and Atrial Fibrillation Hemodynamics under Exercise.
    PLoS One. 2017;12:e0169967.
    PubMed     Abstract available


  185. KONIGSBRUGGE O, Posch F, Antlanger M, Kovarik J, et al
    Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).
    PLoS One. 2017;12:e0169400.
    PubMed     Abstract available


  186. KARAJAMAKI AJ, Kettunen O, Lepojarvi S, Koivurova OP, et al
    Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population.
    PLoS One. 2017;12:e0173855.
    PubMed     Abstract available


  187. KORHONEN M, Parkkonen J, Hedman M, Muuronen A, et al
    Morphological features of the left atrial appendage in consecutive coronary computed tomography angiography patients with and without atrial fibrillation.
    PLoS One. 2017;12:e0173703.
    PubMed     Abstract available


  188. FARRE N, Vela E, Cleries M, Bustins M, et al
    Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients.
    PLoS One. 2017;12:e0172745.
    PubMed     Abstract available


  189. SKIELBOE AK, Bandholm TQ, Hakmann S, Mourier M, et al
    Cardiovascular exercise and burden of arrhythmia in patients with atrial fibrillation - A randomized controlled trial.
    PLoS One. 2017;12:e0170060.
    PubMed     Abstract available


  190. GU J, Skals RK, Torp-Pedersen C, Lundbye-Christensen S, et al
    Storage time of intraoperative transfused allogeneic red blood cells is not associated with new-onset postoperative atrial fibrillation in cardiac surgery.
    PLoS One. 2017;12:e0172726.
    PubMed     Abstract available


  191. SMORODINOVA N, Blaha M, Melenovsky V, Rozsivalova K, et al
    Analysis of immune cell populations in atrial myocardium of patients with atrial fibrillation or sinus rhythm.
    PLoS One. 2017;12:e0172691.
    PubMed     Abstract available


  192. HENDRIKX T, Sundqvist M, Sandstrom H, Sahlin C, et al
    Atrial fibrillation among patients under investigation for suspected obstructive sleep apnea.
    PLoS One. 2017;12:e0171575.
    PubMed     Abstract available


  193. ZHANG D, Chen X, Wang Q, Wu S, et al
    Role of the MAPKs/TGF-beta1/TRAF6 signaling pathway in postoperative atrial fibrillation.
    PLoS One. 2017;12:e0173759.
    PubMed     Abstract available


  194. SILAND JE, Geelhoed B, van Gelder IC, van der Harst P, et al
    Telomere length and incident atrial fibrillation - data of the PREVEND cohort.
    PLoS One. 2017;12:e0171545.
    PubMed     Abstract available


  195. WEI W, Liao H, Xue Y, Fang X, et al
    Long-Term Outcomes of Radio-Frequency Catheter Ablation on Ventricular Tachycardias Due to Arrhythmogenic Right Ventricular Cardiomyopathy: A Single Center Experience.
    PLoS One. 2017;12:e0169863.
    PubMed     Abstract available


  196. AHMED FZ, Motwani M, Cunnington C, Kwok CS, et al
    One-Month Global Longitudinal Strain Identifies Patients Who Will Develop Pacing-Induced Left Ventricular Dysfunction over Time: The Pacing and Ventricular Dysfunction (PAVD) Study.
    PLoS One. 2017;12:e0162072.
    PubMed     Abstract available


  197. JABBARI R, Glinge C, Jabbari J, Risgaard B, et al
    A Common Variant in SCN5A and the Risk of Ventricular Fibrillation Caused by First ST-Segment Elevation Myocardial Infarction.
    PLoS One. 2017;12:e0170193.
    PubMed     Abstract available


  198. CALLIZO J, Feltgen N, Ammermann A, Ganser J, et al
    Atrial fibrillation in retinal vascular occlusion disease and non-arteritic anterior ischemic optic neuropathy.
    PLoS One. 2017;12:e0181766.
    PubMed     Abstract available


  199. BHATTACHARYYA S, Bhakta M, Munshi NV
    Phenotypically silent Cre recombination within the postnatal ventricular conduction system.
    PLoS One. 2017;12:e0174517.
    PubMed     Abstract available


  200. WANG M, Cai S, Ding W, Deng Y, et al
    Efficacy and effects on cardiac function of radiofrequency catheter ablation vs. direct current cardioversion of persistent atrial fibrillation with left ventricular systolic dysfunction.
    PLoS One. 2017;12:e0174510.
    PubMed     Abstract available


  201. TE AL, Higa S, Chung FP, Lin CY, et al
    The use of a novel signal analysis to identify the origin of idiopathic right ventricular outflow tract ventricular tachycardia during sinus rhythm: Simultaneous amplitude frequency electrogram transformation mapping.
    PLoS One. 2017;12:e0173189.
    PubMed     Abstract available


  202. ZHANG W, Lu M, Zhang C, Zhang R, et al
    Therapeutic hypothermia increases the risk of cardiac arrhythmia for perinatal hypoxic ischaemic encephalopathy: A meta-analysis.
    PLoS One. 2017;12:e0173006.
    PubMed     Abstract available


  203. RIAD FS, Razak E, Saba S, Shalaby A, et al
    Recent heart rate history affects QT interval duration in atrial fibrillation.
    PLoS One. 2017;12:e0172962.
    PubMed     Abstract available


  204. QI W, Zhang N, Korantzopoulos P, Letsas KP, et al
    Serum glycated hemoglobin level as a predictor of atrial fibrillation: A systematic review with meta-analysis and meta-regression.
    PLoS One. 2017;12:e0170955.
    PubMed     Abstract available


  205. HWANG M, Lim B, Song JS, Yu HT, et al
    Ganglionated plexi stimulation induces pulmonary vein triggers and promotes atrial arrhythmogenecity: In silico modeling study.
    PLoS One. 2017;12:e0172931.
    PubMed     Abstract available


  206. KILKENNY MF, Dunstan L, Busingye D, Purvis T, et al
    Knowledge of risk factors for diabetes or cardiovascular disease (CVD) is poor among individuals with risk factors for CVD.
    PLoS One. 2017;12:e0172941.
    PubMed     Abstract available


  207. WAN H, Wu S, Yang Y, Zhu J, et al
    Plasma fibrin D-dimer and the risk of left atrial thrombus: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0172272.
    PubMed     Abstract available


  208. CHANG JY, Jung S, Park H, Han MK, et al
    Major vessel occlusion may predict subtherapeutic anticoagulation intensity and feasibility of administration of intravenous thrombolytics.
    PLoS One. 2017;12:e0170978.
    PubMed     Abstract available


  209. SHEHAB A, Zubaid M, Bhagavathula AS, Rashed WA, et al
    Sex differences in management and outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events (Gulf SAFE).
    PLoS One. 2017;12:e0175405.
    PubMed     Abstract available


  210. BROCKLEHURST P, Ni H, Zhang H, Ye J, et al
    Electro-mechanical dynamics of spiral waves in a discrete 2D model of human atrial tissue.
    PLoS One. 2017;12:e0176607.
    PubMed     Abstract available


  211. JAAKKOLA S, Nuotio I, Kiviniemi TO, Virtanen R, et al
    Incidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation-The EWA study.
    PLoS One. 2017;12:e0175975.
    PubMed     Abstract available


  212. ARTS DL, Abu-Hanna A, Medlock SK, van Weert HC, et al
    Effectiveness and usage of a decision support system to improve stroke prevention in general practice: A cluster randomized controlled trial.
    PLoS One. 2017;12:e0170974.
    PubMed     Abstract available


  213. RIZOS T, Bartsch AJ, Johnson TD, Dittgen F, et al
    Voxelwise distribution of acute ischemic stroke lesions in patients with newly diagnosed atrial fibrillation: Trigger of arrhythmia or only target of embolism?
    PLoS One. 2017;12:e0177474.
    PubMed     Abstract available


  214. ZHAI XW, Zhang L, Guo YF, Yang Y, et al
    The IK1/Kir2.1 channel agonist zacopride prevents and cures acute ischemic arrhythmias in the rat.
    PLoS One. 2017;12:e0177600.
    PubMed     Abstract available


  215. ONDRAKOVA M, Motovska Z, Waldauf P, Knot J, et al
    Antithrombotic therapy of patients with atrial fibrillation discharged after major non-cardiac surgery. 1-year follow-up. Sub-analysis of PRAGUE 14 study.
    PLoS One. 2017;12:e0177519.
    PubMed     Abstract available


  216. WILLIS TA, West R, Rushforth B, Stokes T, et al
    Variations in achievement of evidence-based, high-impact quality indicators in general practice: An observational study.
    PLoS One. 2017;12:e0177949.
    PubMed     Abstract available


  217. SUKTITIPAT B, Sathirareuangchai S, Roothumnong E, Thongnoppakhun W, et al
    Molecular investigation by whole exome sequencing revealed a high proportion of pathogenic variants among Thai victims of sudden unexpected death syndrome.
    PLoS One. 2017;12:e0180056.
    PubMed     Abstract available


  218. KAESE S, Larbig R, Rohrbeck M, Frommeyer G, et al
    Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis.
    PLoS One. 2017;12:e0180029.
    PubMed     Abstract available


  219. SON MK, Lim NK, Kim HW, Park HY, et al
    Risk of ischemic stroke after atrial fibrillation diagnosis: A national sample cohort.
    PLoS One. 2017;12:e0179687.
    PubMed     Abstract available


  220. LUO C, Wang K, Zhang H
    In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.
    PLoS One. 2017;12:e0179515.
    PubMed     Abstract available


  221. CASTAN C, Munch A, Mahling M, Haffner L, et al
    Factors associated with delayed defibrillation in cardiopulmonary resuscitation: A prospective simulation study.
    PLoS One. 2017;12:e0178794.
    PubMed     Abstract available


  222. QIN M, Li L, Liu X, Liu T, et al
    Neural substrate of posterior left atrium: A novel modulation for inducibility and remodeling of atrial fibrillation in canine.
    PLoS One. 2017;12:e0176626.
    PubMed     Abstract available


  223. ANDERSSON T, Magnuson A, Bryngelsson IL, Frobert O, et al
    Patients with atrial fibrillation and outcomes of cerebral infarction in those with treatment of warfarin versus no warfarin with references to CHA2DS2-VASc score, age and sex - A Swedish nationwide observational study with 48 433 patients.
    PLoS One. 2017;12:e0176846.
    PubMed     Abstract available


  224. GARCIA-GUDINO D, Landa E, Mendoza-Temis J, Albarado-Ibanez A, et al
    Enhancement of early warning properties in the Kuramoto model and in an atrial fibrillation model due to an external perturbation of the system.
    PLoS One. 2017;12:e0181953.
    PubMed     Abstract available


  225. PERSYN E, Karakachoff M, Le Scouarnec S, Le Clezio C, et al
    DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease.
    PLoS One. 2017;12:e0179364.
    PubMed     Abstract available


  226. FERRER-ALBERO A, Godoy EJ, Lozano M, Martinez-Mateu L, et al
    Non-invasive localization of atrial ectopic beats by using simulated body surface P-wave integral maps.
    PLoS One. 2017;12:e0181263.
    PubMed     Abstract available


  227. SJOGREN V, Bystrom B, Renlund H, Svensson PJ, et al
    Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study.
    PLoS One. 2017;12:e0181000.
    PubMed     Abstract available


  228. YOKOYAMA T, Lee JK, Miwa K, Opthof T, et al
    Quantification of sympathetic hyperinnervation and denervation after myocardial infarction by three-dimensional assessment of the cardiac sympathetic network in cleared transparent murine hearts.
    PLoS One. 2017;12:e0182072.
    PubMed     Abstract available


  229. LIU X, Sun L, Chen J, Jin Y, et al
    Effects of local cardiac denervation on cardiac innervation and ventricular arrhythmia after chronic myocardial infarction.
    PLoS One. 2017;12:e0181322.
    PubMed     Abstract available


  230. TAO S, Way SF, Garland J, Chrispin J, et al
    Ablation as targeted perturbation to rewire communication network of persistent atrial fibrillation.
    PLoS One. 2017;12:e0179459.
    PubMed     Abstract available


  231. MATONO T, Kutsuna S, Kato Y, Katanami Y, et al
    Role of classic signs as diagnostic predictors for enteric fever among returned travellers: Relative bradycardia and eosinopenia.
    PLoS One. 2017;12:e0179814.
    PubMed     Abstract available


  232. COLLINGS SL, Lefevre C, Johnson ME, Evans D, et al
    Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany.
    PLoS One. 2017;12:e0185642.
    PubMed     Abstract available


  233. TEMU TM, Lane KA, Shen C, Ng'ang'a L, et al
    Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya.
    PLoS One. 2017;12:e0185204.
    PubMed     Abstract available


  234. LACKERMAIR K, Clauss S, Voigt T, Klier I, et al
    Alteration of Endothelin 1, MCP-1 and Chromogranin A in patients with atrial fibrillation undergoing pulmonary vein isolation.
    PLoS One. 2017;12:e0184337.
    PubMed     Abstract available


  235. FARRELL M, Yoneda Z, Montgomery J, Crawford D, et al
    Non-pulmonary vein mediated atrial fibrillation: A novel sub-phenotype.
    PLoS One. 2017;12:e0184354.
    PubMed     Abstract available


  236. SPRENKELER DJ, Tuinenburg AE, Ritsema van Eck HJ, Malik M, et al
    Circadian pattern of short-term variability of the QT-interval in primary prevention ICD patients - EU-CERT-ICD methodological pilot study.
    PLoS One. 2017;12:e0183199.
    PubMed     Abstract available


  237. SONG JS, Wi J, Lee HJ, Hwang M, et al
    Role of atrial wall thickness in wave-dynamics of atrial fibrillation.
    PLoS One. 2017;12:e0182174.
    PubMed     Abstract available


  238. KIENAST R, Handler M, Stoger M, Baumgarten D, et al
    Modeling hypothermia induced effects for the heterogeneous ventricular tissue from cellular level to the impact on the ECG.
    PLoS One. 2017;12:e0182979.
    PubMed     Abstract available


  239. HSIEH WH, Lin CY, Te ALD, Lo MT, et al
    A novel noninvasive surface ECG analysis using interlead QRS dispersion in arrhythmogenic right ventricular cardiomyopathy.
    PLoS One. 2017;12:e0182364.
    PubMed     Abstract available


  240. GONG X, Tang S, Li J, Zhang X, et al
    Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis.
    PLoS One. 2017;12:e0186449.
    PubMed     Abstract available


  241. NAGATA N, Sakurai T, Moriyasu S, Shimbo T, et al
    Impact of INR monitoring, reversal agent use, heparin bridging, and anticoagulant interruption on rebleeding and thromboembolism in acute gastrointestinal bleeding.
    PLoS One. 2017;12:e0183423.
    PubMed     Abstract available


  242. KANG HJ, Kim SW, Son SH
    The feasibility of a heart block with an electron compensation as an alternative whole breast radiotherapy technique in patients with underlying cardiac or pulmonary disease.
    PLoS One. 2017;12:e0184137.
    PubMed     Abstract available


  243. HERMANS BJM, Vink AS, Bennis FC, Filippini LH, et al
    The development and validation of an easy to use automatic QT-interval algorithm.
    PLoS One. 2017;12:e0184352.
    PubMed     Abstract available


  244. CHEN X, Qin M, Jiang W, Zhang Y, et al
    Electrophysiological characteristics of pressure overload-induced cardiac hypertrophy and its influence on ventricular arrhythmias.
    PLoS One. 2017;12:e0183671.
    PubMed     Abstract available


  245. HUSSER D, Ueberham L, Hindricks G, Buttner P, et al
    Rare variants in genes encoding the cardiac sodium channel and associated compounds and their impact on outcome of catheter ablation of atrial fibrillation.
    PLoS One. 2017;12:e0183690.
    PubMed     Abstract available


  246. DIXIT S, Alonso A, Vittinghoff E, Soliman E, et al
    Past alcohol consumption and incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study.
    PLoS One. 2017;12:e0185228.
    PubMed     Abstract available


  247. MANTOVANI A, Rigolon R, Pichiri I, Bonapace S, et al
    Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus.
    PLoS One. 2017;12:e0185459.
    PubMed     Abstract available


  248. LIU Y, Wei J, Wong King Yuen SM, Sun B, et al
    CPVT-associated cardiac ryanodine receptor mutation G357S with reduced penetrance impairs Ca2+ release termination and diminishes protein expression.
    PLoS One. 2017;12:e0184177.
    PubMed     Abstract available


  249. MERCADER MA, He D, Sharma AC, Marchitto MC, et al
    Selective autonomic stimulation of the AV node fat pad to control rapid post-operative atrial arrhythmias.
    PLoS One. 2017;12:e0183804.
    PubMed     Abstract available


  250. KHARCHE SR, Vigmond E, Efimov IR, Dobrzynski H, et al
    Computational assessment of the functional role of sinoatrial node exit pathways in the human heart.
    PLoS One. 2017;12:e0183727.
    PubMed     Abstract available


  251. ALVES-CABRATOSA L, Garcia-Gil M, Comas-Cufi M, Ponjoan A, et al
    Statins and new-onset atrial fibrillation in a cohort of patients with hypertension. Analysis of electronic health records, 2006-2015.
    PLoS One. 2017;12:e0186972.
    PubMed     Abstract available


  252. AHN J, Kim HJ, Choi JI, Lee KN, et al
    Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: A meta-analysis.
    PLoS One. 2017;12:e0185680.
    PubMed     Abstract available


  253. KOENE RJ, Norby FL, Maheshwari A, Rooney MR, et al
    Predictors of sudden cardiac death in atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.
    PLoS One. 2017;12:e0187659.
    PubMed     Abstract available


  254. QUINTANA-VILLAMANDOS B, Gomez de Diego JJ, Delgado-Martos MJ, Munoz-Valverde D, et al
    Dronedarone produces early regression of myocardial remodelling in structural heart disease.
    PLoS One. 2017;12:e0188442.
    PubMed     Abstract available


  255. HALD J, Poulsen PB, Qvist I, Holm L, et al
    Opportunistic screening for atrial fibrillation in a real-life setting in general practice in Denmark-The Atrial Fibrillation Found On Routine Detection (AFFORD) non-interventional study.
    PLoS One. 2017;12:e0188086.
    PubMed     Abstract available


  256. SETHI NJ, Feinberg J, Nielsen EE, Safi S, et al
    The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and Trial Sequential Analysis.
    PLoS One. 2017;12:e0186856.
    PubMed     Abstract available


  257. DA SILVA AA, Hall JE, do Carmo JM
    Leptin reverses hyperglycemia and hyperphagia in insulin deficient diabetic rats by pituitary-independent central nervous system actions.
    PLoS One. 2017;12:e0184805.
    PubMed     Abstract available


  258. VESTERGAARD AS, Skjoth F, Larsen TB, Ehlers LH, et al
    The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: A systematic review and meta-regression analysis.
    PLoS One. 2017;12:e0188482.
    PubMed     Abstract available


  259. YANG PS, Park YA, Kim TH, Uhm JS, et al
    Which patients recur as atrial tachycardia rather than atrial fibrillation after catheter ablation of atrial fibrillation?
    PLoS One. 2017;12:e0188326.
    PubMed     Abstract available


  260. MORTENSEN LM, Lundbye-Christensen S, Schmidt EB, Calder PC, et al
    Long-chain n-3 and n-6 polyunsaturated fatty acids and risk of atrial fibrillation: Results from a Danish cohort study.
    PLoS One. 2017;12:e0190262.
    PubMed     Abstract available


  261. LEE SR, Choi EK, Han KD, Cha MJ, et al
    Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study.
    PLoS One. 2017;12:e0189495.
    PubMed     Abstract available


  262. ROBERTS PR, Zachariah D, Morgan JM, Yue AM, et al
    Monitoring of arrhythmia and sudden death in a hemodialysis population: The CRASH-ILR Study.
    PLoS One. 2017;12:e0188713.
    PubMed     Abstract available


  263. LIM B, Hwang M, Song JS, Ryu AJ, et al
    Effectiveness of atrial fibrillation rotor ablation is dependent on conduction velocity: An in-silico 3-dimensional modeling study.
    PLoS One. 2017;12:e0190398.
    PubMed     Abstract available


    January 2016
  264. SASAOKA S, Matsui T, Hane Y, Abe J, et al
    Time-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug Events.
    PLoS One. 2016;11:e0164309.
    PubMed     Abstract available


  265. YU P, Pan Y, Wang Y, Wang X, et al
    External Validation of a Case-Mix Adjustment Model for the Standardized Reporting of 30-Day Stroke Mortality Rates in China.
    PLoS One. 2016;11:e0166069.
    PubMed     Abstract available


  266. BAJAJ NS, Kalra R, Patel N, Hashim T, et al
    Comparison of Approaches for Stroke Prophylaxis in Patients with Non-Valvular Atrial Fibrillation: Network Meta-Analyses of Randomized Controlled Trials.
    PLoS One. 2016;11:e0163608.
    PubMed     Abstract available


  267. BING R, Chow V, Lau JK, Thomas L, et al
    Prevalence of Echocardiography Use in Patients Hospitalized with Confirmed Acute Pulmonary Embolism: A Real-World Observational Multicenter Study.
    PLoS One. 2016;11:e0168554.
    PubMed     Abstract available


  268. JAAKKOLA J, Mustonen P, Kiviniemi T, Hartikainen JE, et al
    Stroke as the First Manifestation of Atrial Fibrillation.
    PLoS One. 2016;11:e0168010.
    PubMed     Abstract available


  269. HANON O, Chaussade E, Gueranger P, Gruson E, et al
    Patient-Reported Treatment Satisfaction with Rivaroxaban for Stroke Prevention in Atrial Fibrillation. A French Observational Study, the SAFARI Study.
    PLoS One. 2016;11:e0166218.
    PubMed     Abstract available


  270. HUNG YC, Cheng YC, Muo CH, Chiu HE, et al
    Adjuvant Chinese Herbal Products for Preventing Ischemic Stroke in Patients with Atrial Fibrillation.
    PLoS One. 2016;11:e0159333.
    PubMed     Abstract available


  271. KUSSMAN BD, Aasted CM, Yucel MA, Steele SC, et al
    Capturing Pain in the Cortex during General Anesthesia: Near Infrared Spectroscopy Measures in Patients Undergoing Catheter Ablation of Arrhythmias.
    PLoS One. 2016;11:e0158975.
    PubMed     Abstract available


  272. PALLISGAARD JL, Gislason GH, Torp-Pedersen C, Lee CJ, et al
    Risk of Ischemic Stroke, Hemorrhagic Stroke, Bleeding, and Death in Patients Switching from Vitamin K Antagonist to Dabigatran after an Ablation.
    PLoS One. 2016;11:e0161768.
    PubMed     Abstract available


  273. COLEMAN CI, Tangirala M, Evers T
    Treatment Persistence and Discontinuation with Rivaroxaban, Dabigatran, and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United States.
    PLoS One. 2016;11:e0157769.
    PubMed     Abstract available


  274. VENE N, Mavri A, Gubensek M, Tratar G, et al
    Risk of Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation After Dabigatran or Rivaroxaban Discontinuation - Data from the Ljubljana Registry.
    PLoS One. 2016;11:e0156943.
    PubMed     Abstract available


  275. HSIAO SH, Chiou KR
    Diastolic Heart Failure Predicted by Left Atrial Expansion Index in Patients with Severe Diastolic Dysfunction.
    PLoS One. 2016;11:e0162599.
    PubMed     Abstract available


  276. BATSON S, Sutton A, Abrams K
    Exploratory Network Meta Regression Analysis of Stroke Prevention in Atrial Fibrillation Fails to Identify Any Interactions with Treatment Effect.
    PLoS One. 2016;11:e0161864.
    PubMed     Abstract available


  277. THALER MA, Feurer R, Thaler C, Sonntag N, et al
    Activated Protein C Resistance Does Not Increase Risk for Recurrent Stroke or Death in Stroke Patients.
    PLoS One. 2016;11:e0160382.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: